NOVEL BIOMARKER FOR ANALYZING PROGNOSIS OF ESOPHAGEAL CANCER AND USES THEREOF

摘要

Provided in the present invention is a novel biomarker with respect to the analysis of the esophageal cancer prognosis. The present invention is based on the research result, which exhibits a pattern increased in a patient having the negative prognosis in comparison with a patient having the positive prognosis of the expression of SMA, FSP1, and PDGFRα expressed in cancer-associated fibroblasts. Accordingly, the analysis of the esophageal cancer prognosis can be performed by using the marker of the present invention in a rapid and accurate manner.;COPYRIGHT KIPO 2016